Fundz

Gossamer Bio, Inc. reported raising $230 Million in an initial SEC Form D filing, from an offering of $230 Million

PUBLIC · GOSSAug 01, 2018

Amount Raised

$230 Million

$230 Million sold, per SEC Form D (first sale Aug 1, 2018)

Round Type

Venture

San DiegoBiotechnologyTherapeuticsPharmaceuticalBiopharma

Who to call at Gossamer Bio, and when

A new round usually means Gossamer Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gossamer Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gossamer Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gossamer Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gossamer Bio

Location

3013 SCIENCE PARK

San Diego, California, United States

About

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gossamer Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsFaheem H., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Gossamer Bio's next move

See what Strategic adds

Gossamer Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.